Alzheimer’s disease has long resisted simple answers, yet a growing body of research is pointing to an unexpected ally ...

A new review highlights five major ways microplastics can harm the brain, raising concerns that they may worsen ...

Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

ST. PAUL, Minn., Oct. 6 (UPI) --Spanish and Chinese scientists said Monday they have used specifically tailored nanoparticles to clear out build-ups of a key toxin linked to Alzheimer's disease in the ...

Recent clinical trials of Novo Nordisk’s blockbuster GLP-1 drug semaglutide for Alzheimer’s disease may have failed to show ...

The brain's health depends on more than just its neurons. A complex network of blood vessels and immune cells acts as the brain's dedicated guardians-controlling what enters, cleaning up waste, and ...

A common blood test can flag early Alzheimer's disease patients who are four times more likely to experience rapid brain decline, a new study says. The test -- the triglyceride-glucose (TyG) index -- ...

Trontinemab, utilizing Roche’s Brainshuttle technology, boosts drug delivery across the blood-brain barrier, driving robust ...

Scientists have discovered what could be a breakthrough in the treatment of Alzheimer’s disease. Over 7 million Americans are living with Alzheimer’s, which slowly erodes memory, cognitive skills and ...

Rahul Sidhu does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...